| Mapping the human genetic architecture of COVID-19. CHG Initiative, MEK Niemi, J Karjalainen, RG Liao, BM Neale, M Daly, ... Nature, 2021 | 856* | 2021 |
| Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases Y Chen, T Lu, U Pettersson-Kymmer, ID Stewart, G Butler-Laporte, ... Nature genetics 55 (1), 44-53, 2023 | 432 | 2023 |
| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... JAMA internal medicine 181 (3), 353-360, 2021 | 351* | 2021 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 310 | 2022 |
| A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity S Zhou, G Butler-Laporte, T Nakanishi, DR Morrison, J Afilalo, M Afilalo, ... Nature medicine 27 (4), 659-667, 2021 | 265 | 2021 |
| Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ... Clinical Microbiology and Infection 28 (8), 1076-1084, 2022 | 179 | 2022 |
| Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study G Butler-Laporte, T Nakanishi, V Mooser, DR Morrison, T Abdullah, ... PLoS medicine 18 (6), e1003605, 2021 | 153* | 2021 |
| A first update on mapping the human genetic architecture of COVID-19 Writing group lead Andrews Shea J. 6 Kanai Masahiro 3 Cordioli Mattia 7, ... Nature 608 (7921), E1-E10, 2022 | 139 | 2022 |
| Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality T Nakanishi, S Pigazzini, F Degenhardt, M Cordioli, G Butler-Laporte, ... The Journal of clinical investigation 131 (23), 2021 | 120 | 2021 |
| Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals JA Kosmicki, JE Horowitz, N Banerjee, R Lanche, A Marcketta, E Maxwell, ... The American Journal of Human Genetics 108 (7), 1350-1355, 2021 | 119* | 2021 |
| Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis O Del Corpo, G Butler-Laporte, DC Sheppard, MP Cheng, EG McDonald, ... Clinical Microbiology and Infection 26 (9), 1137-1143, 2020 | 114 | 2020 |
| Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19 JE Huffman, G Butler-Laporte, A Khan, E Pairo-Castineira, TG Drivas, ... Nature genetics 54 (2), 125-127, 2022 | 112* | 2022 |
| Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis TC Lee, S Murthy, O Del Corpo, J Senécal, G Butler-Laporte, ZN Sohani, ... Clinical Microbiology and Infection 28 (9), 1203-1210, 2022 | 88 | 2022 |
| Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 G Povysil, G Butler-Laporte, N Shang, C Wang, A Khan, M Alaamery, ... The Journal of clinical investigation 131 (14), 2021 | 86* | 2021 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 67 | 2023 |
| Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment N Winters, G Butler-Laporte, D Menzies European Respiratory Journal 46 (5), 1461-1470, 2015 | 67 | 2015 |
| Novel genes and sex differences in COVID-19 severity R Cruz, S Diz-de Almeida, M López de Heredia, I Quintela, FC Ceballos, ... Human molecular genetics 31 (22), 3789-3806, 2022 | 66 | 2022 |
| Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study G Butler-Laporte, D Kreuzer, T Nakanishi, A Harroud, V Forgetta, ... Open forum infectious diseases 7 (11), ofaa450, 2020 | 55 | 2020 |
| Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity S Yoshiji, G Butler-Laporte, T Lu, JDS Willett, CY Su, T Nakanishi, ... Nature Metabolism 5 (2), 248-264, 2023 | 52 | 2023 |
| MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis G Butler-Laporte, S De L’Étoile-Morel, MP Cheng, EG McDonald, TC Lee Journal of Infection 77 (6), 489-495, 2018 | 52 | 2018 |
J Brent RichardsProfessor, McGill University. CEO 5 Prime SciencesE-mail megerősítve itt: mcgill.ca